TABITUXIMAB
UNII TWL5LY57R1

Substance Identification & Data

This profile provides standardized clinical and technical data for Tabituximab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TWL5LY57R1.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1644134-10-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
TWL5LY57R1
CAS Registry Number
1644134-10-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TABITUXIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C170383
National Cancer Institute reference terminology for clinical and research data.
INN ID
10291
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tabituximab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TABITUXIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(FRIZZLED RECEPTOR FRIZZLED-10) (HUMAN-MUS MUSCULUS MONOCLONAL OTSA101 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL OTSA101 LIGHT CHAIN, DIMER
TABITUXIMAB [INN]

Technical Codes

OTSA-101

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus